Table 2.
Receipt of guideline recommended care processes
| Care process | GRS cluster (n=1440) | Standard care cluster (n=1610) | Total (n=3050) |
|---|---|---|---|
| Total | 8121/10 505 (77.3) | 9008/11 968 (75.3) | 17 129/22 473 (76.2) |
| Aspirin | 1202/1248 (96.3) | 1273/1345 (94.6) | 2475/2593 (95.4) |
| Ischaemia testing | 30/110 (27.3) | 12/59 (20.3) | 42/169 (24.9) |
| Aspirin and P2Y12 inhibitor | 799/872 (91.6) | 928/1058 (87.7) | 1727/1930 (89.5) |
| Heparin or fondaparinux | 793/872 (90.9) | 966/1058 (91.3) | 1759/1930 (91.1) |
| Invasive coronary angiography within 72 h | 287/508 (56.5) | 266/521 (51.1) | 553/1029 (53.7) |
| Invasive coronary angiography within 24 h | 40/311 (12.9) | 57/481 (11.9) | 97/792 (12.2) |
| Left ventricular function testing | 777/1440 (54.0) | 1039/1610 (64.5) | 1816/3050 (59.5) |
| ACEi/ARB | 689/824 (83.6) | 815/1006 (81.0) | 1504/1830 (82.2) |
| β blockers | 1205/1440 (83.7) | 1338/1610 (83.1) | 2543/3050 (83.4) |
| Statins | 1345/1440 (93.4) | 1475/1610 (91.6) | 2820/3050 (92.5) |
| Cardiac rehabilitation | 954/1440 (66.3) | 839/1610 (52.1) | 1793/3050 (58.8) |
Data are number of eligible processes received divided by number of patients eligible to receive each process (%).
ACEi=angiotensin converting enzyme inhibitor; ARB=angiotensin receptor blocker; GRS=Global Registry of Acute Coronary Events risk score.